Olivia Cicilia Walewangko, Jonathan Suciono Purnomo, Pranasha Amabella Jo, Valerie Vidian, Juandy Jo
{"title":"成人糖尿病患者的预防性疫苗接种策略：安全性和临床有效性的叙述性回顾。","authors":"Olivia Cicilia Walewangko, Jonathan Suciono Purnomo, Pranasha Amabella Jo, Valerie Vidian, Juandy Jo","doi":"10.7774/cevr.2025.14.e11","DOIUrl":null,"url":null,"abstract":"<p><p>This narrative review analyzed roles of several prophylactic vaccinations in adult patients with diabetes, focusing on their safety profiles and clinical effectiveness. Individuals with diabetes mellitus are at increased risk for infections, making vaccination a critical component of their healthcare. The review assessed various vaccines that are particularly relevant for this population, i.e., vaccines for pneumococcus, meningococcus, severe acute respiratory syndrome coronavirus 2, influenza, herpes zoster, human papillomavirus, and dengue. It highlighted the safety profiles and clinical effectiveness of these vaccines in preventing serious infections and improving long-term health outcomes in diabetic patients. Taken together, this review emphasized the importance of prophylactic vaccinations in reducing infection-related morbidity and mortality as well as encouraged fostering greater adoption and advocacy for immunization programs among diabetic adults.</p>","PeriodicalId":51768,"journal":{"name":"Clinical and Experimental Vaccine Research","volume":"14 2","pages":"101-115"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12046087/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prophylactic vaccination strategies for adult patients with diabetes: a narrative review of safety profiles and clinical effectiveness.\",\"authors\":\"Olivia Cicilia Walewangko, Jonathan Suciono Purnomo, Pranasha Amabella Jo, Valerie Vidian, Juandy Jo\",\"doi\":\"10.7774/cevr.2025.14.e11\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This narrative review analyzed roles of several prophylactic vaccinations in adult patients with diabetes, focusing on their safety profiles and clinical effectiveness. Individuals with diabetes mellitus are at increased risk for infections, making vaccination a critical component of their healthcare. The review assessed various vaccines that are particularly relevant for this population, i.e., vaccines for pneumococcus, meningococcus, severe acute respiratory syndrome coronavirus 2, influenza, herpes zoster, human papillomavirus, and dengue. It highlighted the safety profiles and clinical effectiveness of these vaccines in preventing serious infections and improving long-term health outcomes in diabetic patients. Taken together, this review emphasized the importance of prophylactic vaccinations in reducing infection-related morbidity and mortality as well as encouraged fostering greater adoption and advocacy for immunization programs among diabetic adults.</p>\",\"PeriodicalId\":51768,\"journal\":{\"name\":\"Clinical and Experimental Vaccine Research\",\"volume\":\"14 2\",\"pages\":\"101-115\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12046087/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Vaccine Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7774/cevr.2025.14.e11\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Vaccine Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7774/cevr.2025.14.e11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Prophylactic vaccination strategies for adult patients with diabetes: a narrative review of safety profiles and clinical effectiveness.
This narrative review analyzed roles of several prophylactic vaccinations in adult patients with diabetes, focusing on their safety profiles and clinical effectiveness. Individuals with diabetes mellitus are at increased risk for infections, making vaccination a critical component of their healthcare. The review assessed various vaccines that are particularly relevant for this population, i.e., vaccines for pneumococcus, meningococcus, severe acute respiratory syndrome coronavirus 2, influenza, herpes zoster, human papillomavirus, and dengue. It highlighted the safety profiles and clinical effectiveness of these vaccines in preventing serious infections and improving long-term health outcomes in diabetic patients. Taken together, this review emphasized the importance of prophylactic vaccinations in reducing infection-related morbidity and mortality as well as encouraged fostering greater adoption and advocacy for immunization programs among diabetic adults.
期刊介绍：
Clin Exp Vaccine Res, the official English journal of the Korean Vaccine Society, is an international, peer reviewed, and open-access journal. It covers all areas related to vaccines and vaccination. Clin Exp Vaccine Res publishes editorials, review articles, special articles, original articles, case reports, brief communications, and correspondences covering a wide range of clinical and experimental subjects including vaccines and vaccination for human and animals against infectious diseases caused by viruses, bacteria, parasites and tumor. The scope of the journal is to disseminate information that may contribute to elaborate vaccine development and vaccination strategies targeting infectious diseases and tumors in human and animals. Relevant topics range from experimental approaches to (pre)clinical trials for the vaccine research based on, but not limited to, basic laboratory, translational, and (pre)clinical investigations, epidemiology of infectious diseases and progression of all aspects in the health related issues. It is published printed and open accessed online issues (https://ecevr.org) two times per year in 31 January and 31 July. Clin Exp Vaccine Res is linked to many international databases and is made freely available to institutions and individuals worldwide
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
